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ABSTRACT 
 
A number of studies have cited immune cell infiltration as a mechanism for 
secondary injury following intracerebral hemorrhage. However, the role of monocytes 
remains poorly understood. We hypothesized that monocytes are a beneficial cell type 
that help remove extravasated blood and other pathogenic substances that enter brain 
parenchymal tissue during a hemorrhagic stroke. Using macrophage Fas-induced 
apoptosis (MAFIA) mice, this study documents a time course of monocyte infiltration 
into brain tissue. We then systemically knocked down monocytes prior to initiating an 
intracerebral hemorrhage, and studied the motor and cognitive outcomes relative to a 
vehicle treated group. 
The genetic alteration present in MAFIA mice causes the co-expression of green 
fluorescent protein and a suicide protein, exclusively in monocytes and dendritic cells. 
We established a time course of monocyte infiltration by counting cells expressing green 
fluorescent protein in brain parenchymal tissue at four time points after initiating a severe 
collagenase-induced hemorrhage. We found that at the 48-hour time point there was a 
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significant increase of immune cells infiltrating the core of the lesion relative to that 
observed at 6 hours and 24 hours, and non-significant decline at the 7-day time point. 
Furthermore, the administration of AP20187 to MAFIA mice causes the 
dimerization of the suicide proteins, which initiates Fas-induced apoptosis selectively in 
cells expressing the suicide protein. By administering10uL of AP20187 per animal for 
four consecutive days, we were able to knockdown monocytes both systemically and in 
brain parenchymal tissue following hemorrhage. To investigate the role of monocytes 
following intracerebral hemorrhage, we compared a monocyte-depleted group of MAFIA 
mice to a vehicle-treated group. Both groups underwent a collagenase-induced 
hemorrhage, and then were subjected to wire grip testing and Morris Water Maze. The 
group of monocyte-depleted MAFIA mice performed worse in wire grip testing (p < 
0.02), as well as in the Morris Water Maze test (p < 0.01). Through the course of the 3-
week experiment there was 50% mortality in the monocyte-depleted group, while no 
animals died in the vehicle treated group. 
Both of the functional studies and the mortality data suggest that monocytes play 
an important role following intracerebral hemorrhage. The infiltration data suggests that 
monocytes are recruited to parenchymal tissue after 6 and 24 hours following hemorrhage 
and remain present for at least one week. This time fame offers a large window for 
therapeutic modulation of monocyte recruitment and/or function. Future studies should 
focus on identifying monocytes’ mechanisms of action, as well as improving the MAFIA 
mouse model by controlling for the weight loss and the cause of profound splenomegaly 
observed in the monocyte-depleted group. 
 vi 
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INTRODUCTION 
 
Stroke 
 According to the Center for Disease Control (CDC), stroke is currently the fourth 
leading cause of death in the United States, behind only cardiovascular disease, cancer, 
and lower respiratory infections1. There are two primary types of stroke: ischemic stroke 
and hemorrhagic stroke. Ischemic strokes constitute about 85% of all strokes1, and occur 
when brain tissue does not receive sufficient blood flow due to blockage of vasculature. 
Hemorrhagic strokes are further classified by location, leading to two major subtypes: 
subarachnoid or intracerebral hemorrhages. Subarachnoid hemorrhages occur in the 
subarachnoid space, while intracerebral hemorrhages occur in brain parenchymal tissue2. 
 
Intracerebral Hemorrhage 
Intracerebral hemorrhage (ICH) is the presence of extravasated blood in brain 
parenchymal tissue, originating from a ruptured blood vessel2,3. It is the second most 
common form of stroke, and yet there is no pharmaceutical treatment to date4. The leading 
cause of spontaneous ICH is the rupturing of microaneurysms at the junction of blood 
vessels5. Often times these microaneurysms are induced by chronic hypertension in brain 
vasculature5. Other causes of ICH include: amyloid angiopathy, tumors, arteriovenous 
malformations and fistulas, and cavernous angiomas6. There is significant morbidity and 
mortality associated with ICH7,8,9. In fact, the Oxfordshire Community Stroke Project 
found the actuarial risk of death in persons whom had experience a primary intracerebral 
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hemorrhage to be 62% within a year of hemorrhage7.  
Other studies, have found a correlation between worse outcomes and the 
advancing age of incident6,10,11. A prospective study of 166 patients who experienced ICH, 
conducted by Daverat et al., found that age was the factor most strongly correlated to 
survival at 6 months post ICH10. Furthermore, Gong et al. reported greater neurological 
impairment and more severe edema in older cohorts of a rodent study11. 
 
Pathological Mechanisms of Intracerebral Hemorrhage 
 Primary and Secondary Injury: Intracerebral hemorrhage is a complex and 
multifaceted injury (Figure 1). It can be lethal shortly after ictus, or possibly even weeks 
afterward due to continued pathophysiological mechanisms that have been reported to 
persist at least 4 weeks12. To help evaluate and analyze the pathological mechanisms of 
ICH two categories have been established: primary and secondary injury mechanisms13. 
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 Primary Injury Mechanisms 
 Hematoma Formation and Mass Effect: The majority of brain injury stemming 
from ICH typically occurs within the first few hours13 and is a direct result of hematoma 
formation and of mass effect3,13. While the majority of hemorrhages stop bleeding shortly 
after incident2, a number of studies have noted a significant percentage of cases in which 
hematomas continue to enlarge after 20 hours14,15,16. Continued hematoma enlargement 
hours after onset, and hematomas that have secondary bleeds have deleterious effects on 
patient outcomes, by increasing mass effect5. Hemorrhage growth and edema have a 
synergistic relationship, and together raise intracranial pressure, leading to further mass 
effect damage10. Unfortunately, an optimal therapy that combats primary ICH injury has 
not yet been identified13. However, even after patients stabilize, many continue to 
deteriorate without evidence of hemorrhage growth17, which suggests the potential for 
clinical intervention to ameliorate secondary mechanisms of damage.  
 
 Secondary Injury Mechanisms 
Thrombin: Thrombin is a protein normally present in the blood in its inactive 
form – prothrombin. However, during ICH both the intrinsic and extrinsic coagulation 
cascades are activated, which cleave prothrombin to its active form: thrombin18. The effect 
of thrombin in the presence of brain parenchymal tissue has been studied 
extensively19,20,21,22. It has been reported that at low concentrations (under 100 nanomolar) 
thrombin is neuroprotective21 but at high concentrations (above 500 nanomolar) thrombin 
causes damage22. Also, Xi et al. reported that upon clotting, 1 mL of whole blood can 
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produce 1-2 nanomoles of thrombin18. Thus, in the scenario of intracerebral hemorrhage 
the blood alone that enters parenchymal tissue produces potentially pathological amounts 
of thrombin. It has also been shown that brain tissue itself produces prothrombin4, which 
upon activation by either internal or external coagulation cascade further exacerbates local 
thrombin levels in brain tissue.  Studies have also shown that thrombin is continuously 
released from cerebral hematomas for 14 days after the initial clot formation23, suggesting 
thrombin-induced secondary injury plays a role in patient deterioration well after the onset 
of ICH. 
Together these factors culminate in a high, and sustained, concentration of 
thrombin in brain parenchymal tissue following intracerebral hemorrhage. Thrombin-
induced injury is complex (Figure 2). It can cause damage via the activation of 
compliment, and to parenchymal tissues through the activation of protease activated 
receptors (PARs) and the RhoA receptor. 
 Thrombin activation of the complement system occurs primarily by cleavage of C3 
into C3a anaphylatoxin and C3b in conjunction with C4b2a24. C4b2a enzymatically 
cleaves C5, and then C5b is able to assemble the membrane attack complex (MAC) on 
plasma membranes24. Complement induced cell death may be responsible for neuronal 
and endothelial cell death, as well as the lysis of infiltrating RBCs25. Endothelial cell death 
is important as it could exacerbate bleeding and/or increase blood-brain barrier (BBB) 
breakdown following ICH. Complement induced lysis of RBCs introduces hemoglobin 
into the extracellular space, which exerts oxidative stress on the surrounding tissues13. 
 The second effect of thrombin is through its activation of protease-induced 
 6 
receptors (PAR). Thrombin can activate PARs 1, 3, and 426, as well as RhoA13,18, which is 
also within the PAR superfamily. Although the mechanism is unknown, thrombin 
activation of RhoA induces apoptosis in neurons and astrocytes27, and RhoA inhibitors 
have been shown to mitigate thrombin-mediate cell death18. Thrombin activation of PARs 
1, 3, and 4 have been shown to up-regulate the phosphorylation of mitogen-activated 
protein kinases (MAPK)13,28,29. Neuronal MAPKs recruit microglia, and increase neuronal 
damage measured by terminal deoxynucleotidyl transferase dUPT nick end labeling 
(TUNEL) staining29. Recruitment and subsequent activation of microglia to the area 
surrounding the injury leads to an increase in inflammatory cytokines, specially tumor 
necrosis factor alpha (TNF α) and interleukin-1 beta (IL-1β)30. Secondary to the increase 
of TNF α and IL-1β, Nuclear Factor κB (NF-κB) is activated31, resulting in cell death via 
DNA fragmentation32. 
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Figure 2. Thrombin Induced Secondary ICH Injury. Thrombin activates the 
compliment system, which then is able to form the MAC and cause cell lysis. 
Alternatively, thrombin can trigger PARs causing a range of deleterious 
consequences. (Figure taken and adapted from Babu et al., 2012). 
 
Edema: Previous studies have illustrated the correlation between brain edema and 
poor clinical outcomes5,33. Edema is a dynamic process, driven by diverse factors at 
different time points following ICH. Acute phase (within hours of ICH) edema is dictated 
by hydrostatic pressure as serum from extravasated blood diffuses into the tissues 
surrounding the hemorrhage5, subacute phase (>2 days post ICH) edema is characterized 
by a more porous BBB brought on by thrombin-induced endothelial cell death5,13, and late 
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phase edema is driven by RBC lysis, and ensuing oxidative stress from local hemoglobin5. 
 Inflammatory Response: The inflammatory response to ICH consists of both 
cellular and molecular constituents. The cellular component includes resident microglia 
and peripheral leukocytes that infiltrate parenchymal tissue34. The molecular elements of 
the inflammatory response are produced by the cellular component, and consist of 
cytokines, chemokines, proteases, and reactive oxygen intermediates (ROI)34,35. 
 The first cells that display inflammatory behavior are the resident microglia34. 
While the primary goal of microglia is hypothesized to clear the hematoma, they also 
release a variety of cytokines and ROIs36–39. Among the cytokines known to be produced 
by activated microglia are TNF α and IL-1β13,34, which both induce peripheral leukocytes 
to infiltrate brain parenchymal tissue, as well as exacerbate cerebral edema. While early 
microglial activity may be deleterious, they continue to be activated for 3-4 weeks after 
ictus, and thus require further investigation to best understand how to modulate their 
activity following ICH34. 
 Research in both animal and clinical studies have offered evidence of leukocytes 
playing a role in ICH12,40–44. In a mouse collagenase-induced hemorrhage model, Wang 
and Tsirka reported that neutrophil infiltration began as early as 4 hours, and peaked at 3 
days41. Neutrophils and monocytes are known to release inflammatory cytokines and ROIs 
(similar to microglia), as well as pro-inflammatory proteases, specifically matrix 
metalloproteinases (MMPs)39,45. MMPs disrupt the BBB by degrading intracellular matrix, 
which facilitates further leukocyte infiltration13. In a study published by Wang and Tsirka 
in 2005, inhibition of MMPs concurrently provided neuroprotection and a reduction in 
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neutrophil infiltration in a rodent model38. The exact role and mechanisms of neutrophil 
action following ICH is the subject of continued investigation. 
 Monocytes are another type of leukocyte known to infiltrate brain tissue following 
injury, and have been implicated in neuronal cell death and functional deficit46,47. In 
addition to entrance during a hemorrhage, monocytes are drawn to the site of injury by 
chemokines, primarily CCL248. CCL2 is synthesized at a basal level by epithelial cells, 
but its production is increased by 290 fold in response to elevated IL-1β and TNF α as 
seen following ICH46. However, besides in response to the massive up-regulation of 
CCL2, little is known about how monocytes enter brain parenchymal tissue and their role 
once present at the site of injury46. 
 Monocytes’ ability phagocytosis RBCs and other dead and dying cells suggests 
they may play a critical role in the clean up process. However, their ability to synthesize 
pro-inflammatory cytokines, such as IL-1β and TNF α, encourage further immune cell 
infiltration through disruption of the BBB by the secretion of MMPs, and ability to 
generate ROIs, suggests their potential to be major contributors of secondary injury 
following ICH. 
 
Potential of Research in Stroke 
According to the US Department of Health and Human Services, stroke has been 
among the top four leading causes of death for over five decades in the United States49. It 
also is a growing problem as hospitalizations for ICH increased by 18-19% from 1990 to 
20003,50. These statistics along with the country’s aging population, suggests that stroke is 
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poised to continue being a leading health concern in the foreseeable future51. It is therefore 
an important avenue of study, and one with tremendous potential to increase overall health 
and welfare within our nation, as well as across the globe.  The current study focuses on 
the stroke subtype, intracerebral hemorrhage, and attempts to further elucidate the 
pathological mechanisms leading to poor outcomes with the hope that therapeutic 
strategies can be realized from a better understanding of the nature of ICH. 
Primary injury from ICH occurs rapidly following ictus, which limits therapeutic 
options as most strokes occur outside of a hospital setting. Surgical management, such as 
clot resection and hemorrhage evacuation to reduce intracranial pressure, has not shown 
consistent benefit13,52. Other approaches have shown promise, but also carry the risk of 
serious complications: treatment with recombinant factor VIIa first appeared promising, 
but in phase III clinical trial thromboembolic complications were problematic5,53,54. 
Unfortunately, an optimal therapy for the primary injury of ICH has not yet been 
determined13. 
The interconnected nature of the pathophysiological mechanisms of secondary 
ICH injury complicates therapeutic strategies. With recent advances into the 
understanding of the pathological mechanisms of ICH, therapies to ameliorate secondary 
damage of ICH are currently being investigated13,17,34, and are summarized below in 
(Table 1). This study aims to further characterize the role of monocytes in secondary ICH 
damage, with the hope that modulation of monocyte activity will be a potential therapeutic 
for patients suffering from ICH in the future. 
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Table 1. Potential Therapeutics to Ameliorate Secondary ICH Damage.  
*The clinical study of NXY-059 is currently ongoing. **Kane et al did not report 
on systemic depletion of a specific leukocyte types, but rather systemic depletion 
of all leukocytes via sub-lethal radiation. (Table taken and adapted from Wang and 
Doré, 2007). 
 
Target Strain Reference 
Leukocyte Infiltration 
Global immunosuppression 
through irradiation** 
 
Rat 
 
Kane et al (1992) 
Microglial Activation 
Microglial/macrophage 
inhibitory factor (MIF) 
Minocycline 
 
Mouse 
 
Rat 
 
Wang et al (2003) & 
Wang and Tsirka (2005) 
Power et al (2003) 
Cytokines 
TNFα-specific antisense 
oligodeoxynucleotide 
Adenosine A2A receptor agonist 
Overexpression of IL-1ra 
 
Rat 
Rat 
Rat 
 
Mayne et al (2001a) 
Mayne et al (2001b) 
Masada et al (2001, 2003) 
Matrix Metalloproteinases (MMPs) 
BB-1101 
GM6001 
 
Rat 
Mouse 
 
Rosenberg & Navratil (1997) 
Wang and Tsirka (2005) 
Reactive Oxygen Species 
α-Phenyl-N-tert-butyl nitrone  
NXY-059 
NXY-059 
 
Rat 
Rat 
Clinical 
 
Aronowski & Hall (2005) 
Peeling et al (2001) 
Green and Ashwood * 
Heme Oxygenases 
Tin-mesoporphyrin IX 
Tin-protoporphyrin 
Zinc protoporphyrin 
 
Pig 
Rat 
Rat 
 
Wagner et al (2000) 
Huang et al (2002) 
Gong et al (2006) 
Ferric Iron 
Deferoxamine 
 
Rat 
 
Wan et al (2006) 
 
 
 
 
 
 12 
Specific Area of Study 
Brain inflammation causes secondary damage and can drastically affect the 
survivability and outcome of patients who suffer an ICH7. Research to date has primarily 
investigated the role of microglial activation, neutrophil infiltration, cytokine levels, 
MMPs, and ROIs. However, the role of monocytes following ICH remains largely 
unexplored. The methods of entry into brain tissue, the circumstantial expression of cell 
surface markers, the time course of monocyte infiltration, the production of cytokines, 
phagocytic behavior, and synergistic effects with other cell types are all areas in need of 
study. Research in these areas will better allow potential therapeutic strategies to modulate 
the presence and/or effects of monocytes following ICH.  
 
Specific Study Aims/Objectives 
 As shown in previous studies, a robust immune response, both systemic and local, 
occurs following a stroke. The profile of the immune cells infiltrating brain parenchymal 
tissue has been investigated, however the functions and specific role of these cells, in 
particular monocytes, remains unclear.  
 The goal of this study is to further understand the role of monocytes in brain 
parenchymal tissue following a hemorrhagic stroke.  In the study, we will specifically 
investigate: 
(1) Quantitative assessment of monocytes in the core and peripheral regions of the 
hemorrhage. This knowledge will both demonstrate inflammatory cell 
infiltration and document its time course following hemorrhage. 
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(2) Then, using the transgenic MAFIA mice, we will knockdown the animal’s 
monocytes from before hemorrhage to the peak of inflammatory cell 
infiltration following hemorrhage, determined in aim one.  
(3)  Cognitive and motor testing will be performed in dimerizer and vehicle groups 
to determine the effects of depleting monocytes on cognitive and motor 
functioning, in a hemorrhagic stroke model. 
 
Using the Macrophage Fas-Induced Apoptosis (MAFIA) mice, macrophages were 
readily identifiable because green fluorescent protein (GFP) is encoded into colony 
stimulating factor-1, found primarily in macrophages and dendritic cells. These cells are 
can also be selectively depleted through Fas-activated apoptosis. We hope that increased 
knowledge of the function and effects of monocytes can advance the clinical treatment of 
patients who have suffered a stroke. 
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MATERIALS AND METHODS 
 
Animals 
Macrophage Fas-Induced Apoptosis (MAFIA) mice were procured from Jackson 
Laboratories and were housed in a climate controlled (23±1°C) and ventilated 
environment, with ad libitum access to food and water. Mice between 4 and 20 weeks of 
age were used for experiments. All housing, transportation, and procedures were in 
compliance with Institutional Animal Care and Use Committee of Massachusetts General 
Hospital. 
MAFIA mice have been manipulated to co-express green fluorescent protein 
(GFP) and a suicide protein, on cells synthesizing Colony Stimulating Factor-1 (CSF-1). 
The genetic alteration was introduced onto the CSF-1 receptor, which is specific to 
monocytes and dendritic cells. A schematic is represented (Figure 3) below to show the 
transgene. The suicide gene consists of: an internal ribosome entry site (IRES) to initiate 
synthesis, a modified low-affinity nerve growth factor receptor (LNGFR) directly bound 
to two human FKBP subunits to facilitate binding to neighboring suicide proteins, and 
human Fas to initiate apoptosis when activated55. 
 
 
Figure 3. MAFIA Mouse Transgene Schematic. Synthesis of this gene 
allows for the co-localization of green florescent protein and the suicide 
motif on monocytes and dendritic cells. (Figure taken from Burnett et al., 
2004). 
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Knockdown of GFP Positive Cells 
AP20187 (Clontech Laboritories, Mountain View, CA, USA) is the dimerizing 
agent that causes two FKBP portions of neighboring suicide proteins to dimerize, which 
causes the activation of the Fas domain of the suicide gene, leading to apoptosis. AP20187 
was dissolved in pure ethanol to form a 1mM stock solution, which was then diluted 
1:2500 with a mixture of 4% ethanol, 10% PEG-400, 1.7% Tween, and 84.3% water. The 
vehicle solution was solely the ethanol, PEG-400, Tween, and water in the concentrations 
mentioned above. 
Mice were administered either the dimerizer or the vehicle treatment for 4 
consecutive days. The knockdown group received 10µL of the dimerizer mixed into 
290µL of the vehicle solution, while the vehicle treated group received 300µL of pure 
vehicle solution. Under light anesthesia of 2% isoflurane, the mice were given intravenous 
injections the first day and intraperitoneal injections the remaining 3 days of treatment. 
Figure 4 is a timeline schematic that illustrates the relative time points of treatment, injury, 
and motor testing. 
 16 
 
Figure 4. Experimental Timeline Schematic. 
  
Collagenase Induced Intracerebral Hemorrhage 
The mice underwent the intracerebral hemorrhage surgery on the third day of 
dimerizer/vehicle treatment. The mice were placed in a chamber and exposed to 65% 
nitrogen, 33% oxygen, and 2% isoflurane.  Once anesthetized and unresponsive to a 
pressure stimulus, the mice were then secured in a stereotactic frame by a nose cone and 
bilateral ear bars. The nose cone continued to deliver the anesthetic gas mixture through 
the duration of the surgical procedure.  
A small scalp incision was made to expose the animal’s skull, and a 1mm diameter 
craniotomy was performed at the stereotactic coordinates of 1mm anterior to bregma, and 
2mm lateral of the sagittal suture. A 32-gauge needle was inserted through the craniotomy 
to a depth between 3mm and 3.5mm, allowing the bore of the needle to open into the 
striatum. Over 2.5 minutes, 0.5 µL of Type IV collagenase (0.03 U/0.04 µL) was injected 
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into brain parenchymal tissue. The needle was then left in place for another 3.5 minutes to 
ensure that the collagenase diffused into the appropriate brain region. Once the needle was 
retracted, the skin incision was closed with interrupted sutures and the mice were allowed 
to recover at room temperature. 
 
Tissue Preparation and Florescent Microscopy 
Mice were placed in a chamber and deeply anesthetized by exposure to 63% 
nitrogen, 32% oxygen, and 5% isoflurane. They were then given an intraperitoneal 
injection between 250 and 350 µL of Avertin (tribromoethanol, 20mg/mL). Once mice 
were unresponsive to a minor pain stimulus, their thoracic cavity was opened and a small 
incision was made in the right atrium of the heart. Then a syringe was positioned in the 
left ventricle and the animal was perfused with 15-20mL of 4% paraformaldehyde (PFA). 
The brain was then retrieved, and placed overnight in 4% PFA at room temperature. The 
brain was then dehydrated in 30% sucrose for 1-3 days. 
The brain was then frozen in a bath of isopentane alcohol with dry ice. Then using 
a Microm HM525 (ThermoFisher Scientific Inc., Massachusetts, USA) the brain was 
sliced in the coronal plane, in 14 micron sections. Slides were prepared with a 
representative slice of tissue every 200-250 microns through the length of the lesion. 
Using a Nikon Eclipse Ti-S florescent microscope (Nikon, Tokyo, Japan) and NIS-
Elements BR300 SP7 software, we captured images and counted fluorescently labeled 
GFP cells in x200 fields, selected from 6 – 8 tissue sections. Each animal had 16 fields 
counted through the length of the lesion, 8 core fields and 8 peripheral fields. 
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Leukocyte Analysis via Flow Cytometry 
First, mice were heavily anesthetized with a 5% isoflurane as described above in 
the tissue preparation section. A heparin-coated syringe was then inserted into the thoracic 
cavity, and blood was drawn transcardially. The sample is separated by centrifugation at 
450g and at 20°C. After removing the plasma, ACK Lysing Buffer (Lonza, Basel, 
Switzerland) was then added, at a ratio of 5:1 and gently mixed for 30 minutes. The 
sample was again centrifuged with the settings stated above, and the remaining cells were 
pelleted. The lysed red blood cells and lysing buffer were then removed. 
The nuclear dye, Red Dot (Biotium, Hayward, CA, USA), was then added to the 
samples to facilitate analysis. Samples were incubated with the Red Dot dye for 15 
minutes and after a final wash in PBS, the samples were loaded into a BD Accuri C6 Flow 
Cytometer (San Jose, CA, USA) for analysis.  
 
Functional Behavior Testing 
Wire Grip: Mice were administered the wire grip test on days 4, 6, 8, and 10, as 
illustrated above in Figure 4. The testing apparatus consisted of two wooden dowels, each 
measuring 1.5cm in diameter, suspended a wire 50cm above a bench top. The wire 
measured 2mm in diameter and was held taut between the two dowels. The test included 3 
consecutive trials, in which mice were placed in the center of the wire. Each trial lasted 60 
seconds, after which time removed from the wire and the trial would be scored 0-5 
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according to the grading rubric below in Table 1. The lowest score that describes the 
behavior exhibited by the mouse during a trial was the score assigned. 
 
Table 2. Wire Grip Grading Rubric.  
 
 
Morris Water Maze: The complete test included five hidden trials and a probe 
trial, spread over two days, followed by two visible trials and final probe trial on the third 
day. Mice were allowed to dry off and rest for at least 20 minutes between trials. Water 
maze testing was started on day 17, two weeks after the animals received a hemorrhage. 
An opaque, white, plastic, 1meter diameter tank was filled with room temperature 
water. Four distinct symbols (a circle, triangle, square, and star) were placed on the inside 
of the tub equidistantly spaced, and just above the water line.  A clear, plastic, circular 
platform, with a 10cm diameter, was positioned 15cm from the edge of the tank between 
the circle and square symbols. The water level was adjusted so that the surface of the 
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platform was 1centimeter below water level during hidden trials, and 1cm above water 
level during visible trials. Also during visible trials, a strip of red tape was placed around 
the exposed parameter of the platform, allowing the mice to see the platform from water 
level. 
For hidden trials the tank was set to the above specifications, with the platform 
submerged. Mice were then placed in the water, directly in front of one of the symbols and 
allowed to swim freely for 90 seconds or until they climbed onto the platform. If by 90 
seconds they had not yet found the platform, they were placed on the platform and 
allowed a few seconds to become acquainted with their position within the tank. An 
animal’s score for a single hidden trial score was calculated as the average of four separate 
swims, each swim starting from a different symbol. Visible trials are conducted similarly, 
however the water level was lowered to make the platform visible to the mice. 
In probe trials the platform was removed from the tank. Mice were placed into the 
water between the star and triangle symbols near the tank’s edge, opposite to the location 
where the platform had been. Mice were allowed to swim freely for 1 minute, before being 
rescued from the water. 
A digital camera place above the tank recorded the mouse’s movement during 
probe trials. Version 4.80 of ANY-Maze software (Stoelting Co, Wood Dale IL, USA) 
calculated the time the mouse spent in the quadrant where the platform had been during 
the hidden and visible trials. 
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RESULTS 
 
Intracerebral Hemorrhage Model and Monocyte Infiltration 
Deposition of collagenase into the animal’s striatum caused an ipsilateral 
intracerebral hemorrhage with substantial hematoma formation, but with no detectable 
damage in the contralateral hemisphere. Using MAFIA mice, we hemorrhaged and 
sacrificed mice at 4 different time points to establish the infiltration time course. The time 
points we chose to study were 6 hours, 24 hours, 48 hours, and 7 days post ICH. To 
quantify monocyte infiltration, we perfused the mice at the given time points and prepared 
the tissue for florescent microscopy as described above. We counted GFP positive cells in 
6 animals per time point, and each animal had 16 fields (8 core and 8 periphery). Figure 6 
shows representative core fields at each time point.  
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Figure 5. Monocyte Infiltration Time Course. All of the images were captured from a 
core region of a hemorrhage at 200x, and the scale bar is 20μm. (A) The 6h time point 
shows very few infiltrating GFP positive cells. (B) At the 24h time point GFP positive 
cell infiltration has begun, but has not yet peaked. (C) The 48h time point was the peak 
of GFP positive cell infiltration in our time course study. (D) At 7 days the number of 
GFP positive cells in brain parenchymal tissue has declined. 
 
In both the core and peripheral counts we found an increase in the average number 
of cells per field during the first 48 hours, but by the 7-day time point the average number 
of GFP positive cells had begun to decrease. We found a significant increase in GFP 
positive cells in the core region at the 48-hour time point when compared to the 6-hour 
and 24-hour time points (p < 0.001), but not when compared to the 7-day time point. 
Similarly, we found a significant increase in GFP positive cells in the peripheral region at 
 23 
the 48 hours compared to the 6-hour time point (p < 0.001), but the difference was not 
significant compared to the 24-hour and 7-day time points. Figure 6 summarizes these 
findings. 
 
Figure 6. GFP Positive Cells Counts of Inflammation Time Course. The 
asterisks designate significant differences between treatment groups. Comparing 
the groups with a single asterisk to the 48-hour column represents a p value of < 
0.001. Comparing the double asterisks to the 48-hour column represents a p value 
of < 0.01. 
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Knockdown of GFP Positive Cell Infiltration 
Administration of the dimerizing agent, AP20187, successfully knocked down 
monocytes. Peripheral blood samples were taken from mice after the 4-day treatment 
protocol and analyzed by flow cytometry. The samples were prepared as mentioned 
above, but further analysis was required to interpret the data generated by the flow 
cytometer. Each sample was gated to include only events that were Red Dot positive, and 
within a size range determined by a side-scatter value between 100,000 and 700,000. This 
gating strategy aimed to include only nucleated (Red Dot positive) events roughly the size 
of a single cell (size condition, via side-scatter restriction). Events that fit into these two 
criteria were considered total leukocytes. From this grouping we separated leukocytes that 
were GFP positive, and labeled them monocytes/dendritic cells. A representative plot of 
the total leukocyte group is shown in Figure 7. The vertical axis is side-scatter, and 
representative of the size of the event. The horizontal axis is GFP, and the red vertical line 
is the division between GFP positive and negative events.  
From this graph we were able to find the percentage of monocytes of the total 
leukocyte population. In the example displayed below, the vehicle group monocytes make 
up 14.1% of the sample’s total leukocytes, whereas the dimerizer treated group monocytes 
only make up 0.3% of that sample’s total leukocytes. Comparing 5 vehicle treated animals 
with 5 dimerizer treated animals, our dimerizer protocol knocked down monocytes in 
peripheral blood by 97.8% (p < 0.0005).  
 25 
 
Figure 7. Peripheral Blood Flow Cytometry Analysis. A 95% confidence 
interval established that the knockdown was between 85-100%. 
 
Brain tissue was harvested to investigate if the monocytes knock down was also 
present in brain parenchymal tissue following hemorrhage. Core and peripheral counts of 
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tissue from 6 dimerizer treated MAFIA mice sacrificed 48 hours post ICH were counted 
and compared to the group of 6 untreated MAFIA mice sacrificed at the 48 hour time 
point. We found a 68% reduction of infiltrating monocytes in the core, and a 64% 
reduction in the periphery (both p values < 0.01). 
 
 
Figure 8. Reduction of GFP Positive cells in brain tissue. The dimerizer treated 
mice had significantly lower GFP positive cell in both the core and periphery of 
the lesion. Both groups contained six mice. 
 
Consistent with other studies utilizing the MAFIA mouse model, our dimerizer 
treated mice lost weight55. The vehicle and dimerizer treated groups received the same 
amount of anesthesia, volume of fluid from injections, and hemorrhage surgery. However, 
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their starting body weight by day 5 (Figure 9). The vehicle group also tended to gain back 
their weight by day 17 (beginning of MWM testing), whereas the dimerizer treated group 
still has an average weight loss of 19.6%. It should also be reported that 3 animals from 
the dimerizer treated group were found dead on days 14, 18, 19.  
 
Figure 9. Weight Loss Trend. Both groups lost weight however, only vehicle 
group regained weight. Also it should be noted that the dimerizer treated group’s 
weight lost started before injury. 
 
Wire Grip Motor Test 
Wire grip testing was performed on days 4, 6, 8, and 10, and was scored as 
dictated by the grading rubric in Table 1. The vehicle treated group consisted of 7 mice, 
while the dimerizer treated group contained 6 mice. The 3 individual trail scores of each 
mouse were averaged and that average score was assigned as the mouse’s score for that 
test. Then the scores of all the mice within a given group were averaged to obtain the 
group’s performance for that day’s trial. Figure 10 shows that both groups improved as 
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time progressed, however there was a significant difference between the two groups (p < 
0.035). 
 
Figure 10. Wire Grip Data. In all four days of testing the vehicle group’s average 
was higher than the dimerizer treated group. Also, the improvement shown by the 
vehicle group was greater than the improvement seen in the dimerizer group. 
 
Morris Water Maze Test 
Morris water maze testing began 2 weeks following ICH and lasted for 3 days. The 
vehicle group consisted of 7 animals throughout all of the MWM trials. The dimerizer 
group began with 5 animals, but only 3 animals lived through the testing period. A 
significant difference was found between the vehicle and the dimerizer groups in hidden 
trials 3, 4, and 5 (p < 0.03, 0.003, and 0.005 respectively), however no significant 
difference was found between groups during the visible platform testing. The MWM data 
is summarized in Figure 11. 
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Figure 11. Morris Water Maze Data. The asterisks designate significant 
differences between treatment groups. The single, double, and triple asterisks 
correspond to difference between treatment group with p values of < 0.03, 0.003, 
0.005, respectively. The dimerizer contained 6 mice and the vehicle group 
contained 7 mice.  
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Anatomical Abnormalities 
At the end of the study, on day 21, all mice were euthanatized and examined for 
evidence of an appropriately sized hemorrhage. Upon examination, the dimerizer group 
was found to have profound splenomegaly in comparison to the vehicle group (Figure 12). 
While it is believed that this is a complication of the transient monocyte depletion by the 
administration of AP20187, further study into the cause is recommended. 
 
 
 
Figure 12. Spleen Comparison. Profound splenomegaly was observed in the 
dimerizer treated group after the mice were euthanized on day 21. 
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DISCUSSION 
 
Investigation of Immune Cell Infiltration 
Following intracerebral hemorrhage, the presence of immune cells in brain 
parenchymal tissue has been observed, but their role remains poorly understood. The large 
numbers of GFP cells observed in brain parenchymal tissue in this study suggest that 
monocytes are an important subset among the infiltrating leukocytes. Modulations of 
monocytes, and their function, are avenues for therapeutic development for patients 
suffering from ICH. Noting the lack of literature on monocyte involvement in ICH, this 
study offers a time line specifically for monocyte infiltration, explores the ability, and 
caveats, of the MAFIA mouse model to deplete monocytes, and finally investigates the 
functional outcome of mice that have been depleted of monocytes prior to undergoing 
ICH. 
 
MAFIA Mice and Collagenase Induced ICH 
MAFIA Mice: The genetic alteration of MAFIA allowed for an elegant set of 
experiments in which we could visualize monocytes via their GFP tag, and also could 
selectively deplete them systemically by treatment with AP20187, a dimerizing agent. 
After treatment monocytes underwent a Fas-induced apoptosis, which importantly did not 
instigate an inflammatory response itself. It is also important to note that AP20187 was 
non-toxic when administered to wild type mice55. The MAFIA mouse model allowed us to 
visualize monocytes at any time point and the ability to deplete systemic monocytes for a 
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controlled amount of time, all without adding any confounding factors such as an 
inflammatory response. 
A difficulty with the MAFIA mouse model in our study was interpreting the GFP 
positive cells. As seen in flow cytometric (Figure 7) and brain tissue (Figure 5) data, even 
with meticulous effort in sample preparation there still is notable background signal. In the 
flow cytometry data, there was not a well-defined distinction between GFP positive and 
GFP negative cells, instead there appeared to be a gradient of GFP labeling intensity. Also 
the large GFP positive cells with processes, which appeared only at the 7-day time point, 
indicate that monocytes either undergo morphological changes or some other cell type 
begins expressing GFP by the 7-day time point following ICH. 
During GFP positive cell counts of brain parenchymal tissue to characterize the 
time course of monocytes infiltration the GFP positive cell ranged from 5-10 microns in 
diameter and appeared round without processes. At the 7-day time point we noticed GFP 
positive cells that were larger (10-15 microns) and also had processes. Figure 13 shows an 
example of the varied morphologies of GFP positive cells. Using multiple staining 
modalities would help clarify the end of the infiltration schedule, as well as illustrate 
morphological changes in monocytes. Determining the identity and fate of these large and 
processed cells is an important area for future study, as it will facilitate the interpretation 
of results from studies that use the MAFIA mouse model to study brain injury. 
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Figure 13. Varied Morphologies of GFP Positive Cell in Brain Tissue. The 
images were captured from a peripheral region of a hemorrhage at 200x, and the 
scale bar is 20μm. (A) This tissue was harvested at the 24-hour time point 
following hemorrhage, and illustrates the small, circular, GFP positive cells found 
in all time points. (B) This tissue was harvested at the 7-day time point, and shows 
both the small, circular GFP positive cells as well as the larger, processed cells 
highlighted by the arrows. 
 
 
Collagenase Induced ICH: The two most commonly used intracerebral 
hemorrhage models for studies with mice are an autologous blood injection, and the 
injection of collagenase. We elected to use the collagenase induced hemorrhage model 
because it causes active bleeding within brain tissue, via disruption of the basement 
membrane of capillaries and small vessels. Our study investigated leukocyte infiltration, 
and thus the physical disruption in the vasculature was deemed an important pathological 
characteristic of ICH to be replicated in our injury model. 
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However, our injury model does have limitations and disadvantages. Bacteria-
derived collagenase is known to have toxic effects on brain parenchymal cells5, and the 
hemorrhage has notable variability in hematoma size between animals from the diffusion 
and/or activity of the enzyme. As with all studies of brain injury with rodents, the 
substantially lower ratio of white to gray matter in the mouse brain limits their relevance 
when compared to the human ailment. Even with acknowledging these limitations, our 
study still is able to add to the field’s understanding of the roles monocytes play following 
ICH. 
 
Administration of AP20187 and Knockdown of Monocytes 
The treatment protocol of AP20187, the dimerizing agent, produced significant 
knockdown in our model (data shown in Figures 7 and 8). A number of pilot studies were 
conducted (data not shown) and we found that when the first dose was given intravenously 
a more thorough knockdown was observed. Based on the substantial knockdown seen in 
peripheral blood while using a total of 40μL per animal over the course of 4 days, and 
taking into account the considerable cost of AP20187, we felt the treatment protocol 
described above best suited our study design. 
We noticed a substantial weight loss side effect in the dimerizer treated group, 
which was consistent with previously published studies55. Ultimately, we were unable to 
adequately control for this weight loss, and it remained as a potential confounding factor 
in our study. Within 24 hours of the first dimerizer treatment the mice began to lose 
weight, and they remained underweight the entire length of the study, even though 
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dimerizer was only administered during the first 4 days. Identifying the cause of the 
weight loss, and a proper control group would benefit future studies. 
 
Functional Outcome of Monocyte Depleted Mice Undergoing ICH 
In both the wire grip and Morris Water Maze testing the dimerizer-treated mice 
performed significantly worse than the vehicle group. The wire grip test measure motor 
function acutely after ICH, and is used to examine hemiplegia. The Morris Water Maze 
test measures a combination of both motor function and cognitive processing 
demonstrated by swimming ability and spatial learning and memory. 
The monocyte-depleted group also had a mortality rate of 50% by the end of the 
study, whereas no mortality was observed in the vehicle treated group (Figure 14). 
Together these findings indicate that undergoing intracerebral hemorrhage while depleted 
of monocytes worsens both mortality and functional outcomes. Further research is 
required to determine if the deficit in the monocyte-depleted group is transient or chronic.  
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Figure 14. Mortality Analysis. Over the 3-week study 50% mortality was observed in 
the monocyte-depleted group, while no mortality was seen in the vehicle group. 
 
 
Avenues for Future Study 
As preliminary study into the presence and role of monocytes in brain 
parenchymal tissue following an intracerebral hemorrhage, a number of future study 
objectives were identified. Further investigation into the specificity of GFP expression, 
and the causes of the splenomegaly and weight loss in the dimerizer treated group will 
strengthen the findings here and the continued use of the MAFIA mouse model. A proper 
control for weight loss, and a wider variety of motor and cognitive testing will confirm 
and further characterize the deficits identified in the current study.  
In summary, using the macrophage Fas-induced apoptosis mouse model, this study 
documents a time course of monocyte infiltration into brain parenchymal tissue following 
30 
40 
50 
60 
70 
80 
90 
100 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Pe
rc
en
ta
ge
 o
f A
ni
m
al
s A
liv
e 
Days 
Mortality Analysis 
Vehicle 
Dimerizer 
 37 
hemorrhage. Future studies strengthening the MAFIA mouse model and clarifying our 
findings will potentially open the door for therapeutic modulation of monocyte function. 
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